SCHEMBL11258404

SCHEMBL11258404

CC(=O)c1cc2c(cc1N)C(C)(C)CC2(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 12/20 0.35
RARB P10826 5/20 0.34
RARA P10276 5/20 0.34
RARG P13631 5/20 0.34
RXRB P28702 4/20 0.34
RXRG P48443 3/20 0.34
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 1/20 0.33
CYP26A1 O43174 1/20 0.33
ABCB11 O95342 1/20 0.33
ESR1 P03372 1/20 0.33
PGR P06401 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
CHRM1 P11229 1/20 0.33
DRD1 P21728 1/20 0.33
TBXA2R P21731 1/20 0.33
SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8851470 0.79 RXRA (0.49) RXRARARBRARARARGRXRB
SCHEMBL17968225 0.78 RXRA (0.49) RXRARARBRARARARGRXRB
SCHEMBL11214331 0.78 RXRA (0.49) RXRARARBRARARARGRXRB
SCHEMBL15428156 0.77 PTK2 (0.44) ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL13668270 0.77 RXRA (0.36) RXRARARBRARARARGRXRB
Hydrochloric Acid SCHEMBL17075278 0.75 PTK2 (0.42) ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL12418596 0.74 RXRA (0.50) RXRARARBRARARARGRXRB
SCHEMBL11210750 0.74 ACHE (0.36) RXRARARBRARARARGMEN1
SCHEMBL11214828 0.73 MAPT (0.42) RXRAALDH1A1MEN1BLMKMT2A
SCHEMBL11583537 0.72 ALDH1A1 (0.39) RXRARARBKDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4326055-A ANTITUMOR AGENTS, SKIN DISORDERS, RHEUMATIC DISEASES HOFFMANN-LA ROCHE INC. (US) 1982-04-20 US disclosed